NIH/National Institute of Allergy and Infectious Diseases

NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency. NIAID has been in existence for over 50 years and its primary role is to conduct, support and find effective treatments for infectioius, immunological and allergic diseases. Some of its efforts are conducted in-house, but a significant amount of research funds are awarded to scientists, labs and universities to accomplish NIAID goals. NIAID credits itself with developing new vaccines, new therapies and new diagnostic tests which have aided millions of people.

Address
NIAID Office of Communications and Government Relations 6610 Rockledge Drive, MSC 6612 Bethesda, MD 20892-6612 United States of America
Website
http://www3.niaid.nih.gov/
Wikipedia
http://en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_Diseases

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Diseases, Conditions, Syndromes

NIAID strategic plan details COVID-19 research priorities

Urgent public health measures are needed to control the spread of the novel coronavirus (SARS-CoV-2) and the disease it causes, coronavirus disease 2019, or COVID-19. Scientific research to improve our understanding of the ...

Diseases, Conditions, Syndromes

New coronavirus stable for hours on surfaces: study

The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists ...

HIV & AIDS

Newer anti-HIV drugs safest, most effective during pregnancy

The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available during pregnancy, researchers announced ...

Diseases, Conditions, Syndromes

COVID-19 a reminder of the challenge of emerging infectious diseases

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, ...

Diseases, Conditions, Syndromes

NIH clinical trial of remdesivir to treat COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University ...

page 1 from 39